TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2025-03-04
余忠仁Yu, Chong-Jen
- 計畫主持人
- 執行臨床試驗年資 23 年 9 個月
發表文獻
116筆
31
Chen SY, Huang CK, Peng HC, Tsai HC, Huang SY, Yu CJ, Chien JY. Peak-Inspiratory-Flow-Rate Guided Inhalation Therapy Reduce Severe Exacerbation of COPD. Front Pharmacol. 2021 Jun 29;12:704316. doi: 10.3389/fphar.2021.704316. PMID: 34267665; PMCID: PMC8277232.
32
Wu YL, Tsuboi M, John T, Grohe C, Majem M, Goldman JW, Laktionov K, Kim SW, Kato T, Vu HV, Lu S, Lee KY, Akewanlop C, Yu CJ, de Marinis F, Bonanno L, Domine M, Shepherd FA, Zeng L, Hodge R, Atasoy A, Rukazenkov Y, Herbst RS. A plain language summary of results from the ADAURA study: osimertinib after surgery for patients who have early-stage EGFR-mutated non-small cell lung cancer. Future Oncol. 2021 Dec 1;17(35):4827-4835. doi: 10.2217/fon-2021-0752. Epub 2021 Nov 1. PMID: 34723634.
33
Chung KP, Huang YL, Chen YJ, Juan YH, Hsu CL, Nakahira K, Huang YT, Lin MW, Wu SG, Shih JY, Chang YL, Yu CJ. Multi-kinase framework promotes proliferation and invasion of lung adenocarcinoma through activation of dynamin-related protein 1. Mol Oncol. 2021 Feb;15(2):560-578. doi: 10.1002/1878-0261.12843. Epub 2020 Dec 11. PMID: 33152171; PMCID: PMC7858280.
34
Blechter B, Wong JYY, Agnes Hsiung C, Hosgood HD, Yin Z, Shu XO, Zhang H, Shi J, Song L, Song M, Zheng W, Wang Z, Caporaso N, Burdette L, Yeager M, Berndt SI, Teresa Landi M, Chen CJ, Chang GC, Hsiao CF, Tsai YH, Chen KY, Huang MS, Su WC, Chen YM, Chien LH, Chen CH, Yang TY, Wang CL, Hung JY, Lin CC, Perng RP, Chen CY, Chen KC, Li YJ, Yu CJ, Chen YS, Chen YH, Tsai FY, Jie Seow W, Bassig BA, Hu W, Ji BT, Wu W, Guan P, He Q, Gao YT, Cai Q, Chow WH, Xiang YB, Lin D, Wu C, Wu YL, Shin MH, Hong YC, Matsuo K, Chen K, Pik Wong M, Lu D, Jin L, Wang JC, Seow A, Wu T, Shen H, Fraumeni JF, Yang PC, Chang IS, Zhou B, Chanock SJ, Rothman N, Chatterjee N, Lan Q. Sub-multiplicative interaction between polygenic risk score and household coal use in relation to lung adenocarcinoma among never-smoking women in Asia. Environ Int. 2021 Feb;147:105975. doi: 10.1016/j.envint.2020.105975. Epub 2020 Dec 29. PMID: 33385923; PMCID: PMC8378844.
35
Kim JH, Diaz-Decaro J, Jiang N, Hwang SJ, Choo EJ, Co M, Hastie A, Hui DSC, Irimajiri J, Lee J, Leung EM, Tang H, Tsuru T, Watson P, Wu Z, Yu CJ, Yuan Y, Zahaf T, Cunningham AL, Schuind A. The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults ≥ 50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials. Hum Vaccin Immunother. 2021 Jul 3;17(7):2050-2057. doi: 10.1080/21645515.2020.1859321. Epub 2021 Feb 19. PMID: 33606577; PMCID: PMC8189096.
36
Weng RR, Lu HH, Lin CT, Fan CC, Lin RS, Huang TC, Lin SY, Huang YJ, Juan YH, Wu YC, Hung ZC, Liu C, Lin XH, Hsieh WC, Chiu TY, Liao JC, Chiu YL, Chen SY, Yu CJ, Tsai HC. Epigenetic modulation of immune synaptic-cytoskeletal networks potentiates γδ T cell-mediated cytotoxicity in lung cancer. Nat Commun. 2021 Apr 12;12(1):2163. doi: 10.1038/s41467-021-22433-4. PMID: 33846331; PMCID: PMC8042060.
37
Liu HY, Lu TP, Tao CW, Wu YJ, Huang WC, Hsu CH, Liao WC, Hsu HH, Lin MC, Yu CJ. Incidence of chronic thromboembolic pulmonary hypertension in Taiwan. J Formos Med Assoc. 2021 Sep;120(9):1740-1748. doi: 10.1016/j.jfma.2021.03.022. Epub 2021 Apr 9. PMID: 33846021.
38
Ko HK, Cheng SL, Lin CH, Lin SH, Hsiao YH, Su KC, Yu CJ, Wang HC, Sheu CC, Chiu KC, Perng DW. Blood tryptase and thymic stromal lymphopoietin levels predict the risk of exacerbation in severe asthma. Sci Rep. 2021 Apr 19;11(1):8425. doi: 10.1038/s41598-021-86179-1. PMID: 33875671; PMCID: PMC8055991.
39
Liang SK, Keng LT, Chang CH, Wen YF, Lee MR, Yang CY, Wang JY, Ko JC, Shih JY, Yu CJ. Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort. Front Oncol. 2021 Jan 8;10:590356. doi: 10.3389/fonc.2020.590356. PMID: 33489886; PMCID: PMC7821751.
40
Hyung-Kim J, Diaz-Decaro J, Jiang N, Hwang SJ, Choo EJ, Co M, Hastie A, Hui DSC, Irimajiri J, Lee J, Leung EMF, Tang H, Tsuru T, Watson P, Wu Z, Yu CJ, Yuan Y, Zahaf T, Cunningham AL, Schuind A, on behalf of the ZOE-50/70 Asian study group. The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults ≥50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials. Hum Vaccin Immunother 2021;17: 2050-2057
